1. Home
  2. DVN vs TAK Comparison

DVN vs TAK Comparison

Compare DVN & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Devon Energy Corporation

DVN

Devon Energy Corporation

N/A

Current Price

$49.52

Market Cap

54.0B

Sector

Energy

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

N/A

Current Price

$18.72

Market Cap

57.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DVN
TAK
Founded
1971
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.0B
57.6B
IPO Year
1999
2007

Fundamental Metrics

Financial Performance
Metric
DVN
TAK
Price
$49.52
$18.72
Analyst Decision
Buy
Analyst Count
21
0
Target Price
$50.15
N/A
AVG Volume (30 Days)
9.7M
2.1M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
1.88%
3.24%
EPS Growth
N/A
N/A
EPS
2.60
N/A
Revenue
$17,188,000,000.00
N/A
Revenue This Year
$28.91
$0.16
Revenue Next Year
$8.55
$1.22
P/E Ratio
$19.81
$41.25
Revenue Growth
7.83
N/A
52 Week Low
$31.47
$12.99
52 Week High
$52.71
$18.90

Technical Indicators

Market Signals
Indicator
DVN
TAK
Relative Strength Index (RSI) 69.48 64.39
Support Level $41.93 $17.87
Resistance Level $52.33 $18.85
Average True Range (ATR) 1.16 0.21
MACD 0.15 -0.01
Stochastic Oscillator 96.39 84.66

Price Performance

Historical Comparison
DVN
TAK

About DVN Devon Energy Corporation

Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two-thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. After the merger with Coterra, it will have a foothold in the gas-driven Appalachian Basin as well. At the end of 2025, Devon reported net proved reserves of 2.4 billion barrels of oil equivalent, up from 2.2 billion in 2024. Net production averaged roughly 840,000 barrels of oil equivalent per day in 2025 at a ratio of 73% oil and natural gas liquids and 27% natural gas.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: